WOC® 2010

Article

The largest international ophthalmology congress, the World Ophthalmology Congress 2010 (WOC® 2010) will be held in Berlin from 5 ? 9 June 2010.

The largest international ophthalmology congress, the World Ophthalmology Congress 2010 (WOC® 2010) will be held in Berlin from 5 – 9 June 2010.Twenty years after the reunification, the German capital has evolved into one of the most important metropolises in Europe, thus making it the perfect location for the WOC® 2010.

Scientific Program

The WOC offers an outstanding program, containing top world speakers who will present the most recent scientific knowledge and the latest research findings.

More than
• 650 sessions and courses
• 1,100 speakers
• 1,100 posters
• 600 free papers.

Commercial Exhibition

The attractive accompanying commercial exhibition of the WOC offers more than
• 160 international exhibitors from more than 25 countries
• 20 Non Profit Organizations
• 4,300 sqm

We are looking forward to welcoming you to Berlin in June 2010!

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.